Data di Pubblicazione:
2005
Citazione:
Pharmacokinetic interactions between statins and fibrates / A. Corsini, S. Bellosta, M.H. Davidson. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 96:9 SUPPL. 1(2005), pp. 44K-49K.
Abstract:
Concomitant use of a fibrate and a statin may offer a therapeutic advantage to patients with dyslipidemia, especially in patients whose low-density lipoprotein cholesterol is controlled by statins but whose high-density lipoprotein cholesterol or triglycerides, or both, are not within goal. However, concern about drug-drug interactions may preclude optimal use of combination statin-fibrate therapy. This article reviews the pharmacokinetics between statins and fibrates, addressing risks associated with drug-drug interactions and combination therapy. (copyright) 2005 Elsevier Inc. All rights reserved.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cholesterol blood level; conference paper; coronary artery disease; diabetes mellitus; drug absorption; drug half life; drug safety; dyslipidemia; human; myopathy; priority journal; protein binding; protein metabolism; rhabdomyolysis; risk factor; triacylglycerol blood level; amprenavir; antibiotic agent; atorvastatin; azithromycin; clarithromycin; cyclosporin; digoxin; diltiazem; erythromycin; fenofibrate; fibric acid derivative; fluindostatin; gemfibrozil; glimepiride; hydroxymethylglutaryl coenzyme A reductase inhibitor; itraconazole; ketoconazole; mevinolin; mibefradil; nefazodone; nicotinic acid; pioglitazone; pravastatin; pyrrole derivative; repaglinide; rosiglitazone; rosuvastatin; simvastatin; unindexed drug; warfarin
Elenco autori:
A. Corsini, S. Bellosta, M.H. Davidson
Link alla scheda completa: